Kronos Bio, Inc. - Common Stock (KRON) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q2 2025

Type / Class
Equity / Common Stock
Symbol
KRON on Nasdaq
Price per share
$0.73
Price from insider filings
$0.73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$15,790,194 $0.73 0
2025 Q1 19,132,784 $15,790,464 -$625,095 $0.82 47
2024 Q4 19,649,673 $18,665,607 -$792,901 $0.95 56
2024 Q3 19,704,103 $19,700,585 -$2,248,647 $1.00 52
2024 Q2 20,645,660 $25,556,191 -$1,590,531 $1.24 55
2024 Q1 21,700,397 $28,231,891 -$6,453,069 $1.30 57
2023 Q4 26,745,874 $33,427,928 -$4,590,792 $1.25 58
2023 Q3 30,266,227 $39,328,312 -$2,264,348 $1.30 64
2023 Q2 31,590,966 $54,317,335 -$1,134,783 $1.72 79
2023 Q1 32,396,272 $47,327,276 -$3,356,124 $1.46 86
2022 Q4 34,478,168 $55,850,723 -$2,974,004 $1.62 91
2022 Q3 32,583,348 $109,155,143 -$1,923,779 $3.35 87
2022 Q2 33,191,114 $120,785,861 -$22,548,882 $3.64 88
2022 Q1 38,994,222 $282,032,437 -$21,842,710 $7.23 91
2021 Q4 40,463,070 $549,902,415 -$224,865 $13.59 77
2021 Q3 34,328,715 $719,527,856 -$22,243,161 $20.96 79
2021 Q2 39,757,863 $952,008,187 +$87,935,617 $23.95 76
2021 Q1 33,255,601 $969,057,123 +$55,820,279 $29.27 69
2020 Q4 30,030,576 $889,153,047 +$875,860,923 $29.87 68